Skip to site menu Skip to page content

Characterisation of Spray-Dried Biologics

By Upperton Pharma Solutions
Traditionally, spray drying has been utilised as a useful technology for enhancing the delivery of small molecules via the oral route, in either tablet or capsule dosage forms. However, in more recent times, spray drying has emerged as the method of choice for creating dry powders for delivery in an increasing range of products incorporating oral, pulmonary, nasal, and injectable dosage forms. The expansion of spray drying beyond oral dosage forms has seen this flexible drying technology being used to create dry powders containing small molecules and much larger, more complex molecular structures such as biologics. These dry powder biologics require more complex assay techniques than those typically used for dosage forms containing small molecule APIs. To read more, please download this free white paper.
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content